Patents Assigned to University
  • Patent number: 8980241
    Abstract: A method of covalently bonding a cyclic nitroxide radical compound to a hydrophobic block of a specific hydrophylic-phobic block copolymer, and polymerized cyclic nitroxide radical compound copolymerized in this manner, as well as use of such a compound, for instance, in the medical field are provided. The compound demonstrates long term stability in vivo under reductive environment.
    Type: Grant
    Filed: December 4, 2008
    Date of Patent: March 17, 2015
    Assignee: University of Tsukuba
    Inventors: Yukio Nagasaki, Toru Yoshitomi, Hirofumi Matsui, Aki Hirayama, Takashi Mamiya, Akira Matsumura, Kensuke Suzuki, Hideo Tsurushima, Aiki Marushima, Kazuko Toh, Daisuke Miyamoto
  • Patent number: 8980249
    Abstract: Agonists of growth hormone releasing hormone promote islet graft growth and proliferation in patients. Methods of treating patients comprise the use of these agonists.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: March 17, 2015
    Assignees: University of Miami, Dresden University of Technology
    Inventors: Andrew V. Schally, Barbara Ludwig, Stefan Bornstein, Norman L. Block
  • Patent number: 8980924
    Abstract: A method for treating bisretinoid-mediated macular degeneration in a mammal afflicted therewith comprising administering to the mammal an effective amount of a compound having the structure: or an ester or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: March 17, 2015
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Konstantin Petrukhin, Janet Sparrow, Rando Allikmets
  • Patent number: 8980843
    Abstract: Peptides are provided having leptin receptor agonist activity. The peptides are useful for treating obesity, type II diabetes, appetite control after bariatric surgery, insulin resistance, lipodystrophy and hypothalamic amenorrhea, obesity-related infertility, among other diseases and conditions related to leptin deficiency and/or leptin resistance.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: March 17, 2015
    Assignee: Temple University—of the Commonwealth System of Higher Education
    Inventor: Laszlo Otvos, Jr.
  • Patent number: 8980213
    Abstract: A manganese oxide contains M1, optionally M2, Mn and O. M1 is selected from the group consisting of In, Sc, Y, Dy, Ho, Er, Tm, Yb and Lu. M2 is different from M1, and M2 is selected from the group consisting of Bi, In, Sc, Y, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb and Lu. These ceramic materials are hexagonal in structure, and provide superior materials for gas separation and oxygen storage.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: March 17, 2015
    Assignee: Board of Trustees of Northern Illinois University
    Inventors: Bogdan Dabrowski, Steven Remsen
  • Patent number: 8980225
    Abstract: The presently disclosed subject matter demonstrates that a spin state which has zero magnetic resonance signal, but an extremely long lifetime, can be used to store magnetization, which can then be recovered into an observable transition. Coupled with hyperpolarization techniques, this permits the preparation of a wide range of contrast agent molecules for use in magnetic resonance imaging (MRI) techniques that have long effective relaxation time.
    Type: Grant
    Filed: July 31, 2009
    Date of Patent: March 17, 2015
    Assignee: Duke University
    Inventor: Warren S. Warren
  • Patent number: 8980232
    Abstract: A dental care product comprises an orally acceptable carrier or excipient, and a bacterial resistance copolymer, which comprises a zwitterionic block and a charged anchoring block, wherein the anchoring block binds to tooth surfaces by electrostatic attraction, and the zwitterionic block extends outwardly to reduce the attachment of bacteria to tooth surfaces.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: March 17, 2015
    Assignee: Chung Yuan Christian University
    Inventors: Yung Chang, Yu-Ju Shih, Bor-Shiunn Lee, Ruoh-Chyu Ruaan, Da-Ming Wang, Juin-Yih Lai
  • Patent number: 8980569
    Abstract: Provided herein are methods for identifying a subject afflicted with chronic lymphocytic leukemia who is responsive to treatment with a chemotherapeutic agent by detecting the presence or absence of at least one APOE4 allele in the subject, the presence of an APOE4 allele identifying the subject as responsive to the treatment. Also provided are methods of treating a subject afflicted with chronic lymphocytic leukemia, including administering an estrogenic agent, an androgen withdrawal agent, an apoE4 peptide or mimetic thereof, and/or a chemotherapeutic agent in an amount effective to treat said chronic lymphocytic leukemia. Methods of determining a prognosis for a patient diagnosed with chronic lymphocytic leukemia are also provided. In addition, methods for stratifying a subject into a subgroup of a clinical trial and methods for identifying a patient in a clinical trial of a treatment for chronic lymphocytic leukemia are herein provided.
    Type: Grant
    Filed: January 20, 2011
    Date of Patent: March 17, 2015
    Assignee: Duke University
    Inventors: J. Brice Weinberg, Warren J. Strittmatter
  • Patent number: 8980952
    Abstract: The present invention is directed to therapeutic compounds, treatment methods, and kits affecting the NCCa-ATP channel of neural tissue, including neurons, glia and blood vessels within the nervous system, and methods of using same. The NCCa-ATP channel is newly expressed in neural tissue following injury such as ischemia, and is regulated by the sulfonylurea receptor SUR1, being inhibited by sulfonylurea compounds, e.g., glibenclamide and tolbutamide, and opened by diazoxide. Antagonists of the NCCa-ATP channel, including SUR1 antagonists, are useful in the prevention, diminution, and treatment of injured or diseased neural tissue, including astrocytes, neurons and capillary endothelial cells, that is due to ischemia, tissue trauma, brain swelling and increased tissue pressure, or other forms of brain or spinal cord disease or injury. Agonists of the NCCa-ATP channel may be are useful in the treatment neural tissue where damage or destruction of the tissue, such as a gliotic capsule, is desired.
    Type: Grant
    Filed: February 22, 2006
    Date of Patent: March 17, 2015
    Assignees: University of Maryland, Baltimore, The United States of America as represented by the Dept. of Veterans Affairs
    Inventors: J. Marc Simard, Mingkui Chen
  • Patent number: 8981075
    Abstract: The present invention provides an aptamer that binds to prostate-specific antigen (PSA), the aptamer including: a preceding region having a random polynucleotide sequence consisting of from 1 to 10 nucleotides; a first region, at a 3? end of the preceding region, consisting of nnnnCT wherein each n is independently selected from A, T, G and C; a second region consisting of nnCTTT wherein each n is independently selected from A, T, G and C, and at least one part of the second region is complementary to the first region; and a third region positioned between the first region and the second region and consisting of a random polynucleotide sequence having from 3 to 30 nucleotides.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: March 17, 2015
    Assignee: National University Corporation Tokyo University of Agriculture and Technology
    Inventor: Kazunori Ikebukuro
  • Patent number: 8981168
    Abstract: The present invention provides, among other thing, methods for creating significantly deoxygenated bio-oils form biomass including the steps of providing a feedstock, associating the feedstock with an alkali formate to form a treated feedstock, dewatering the treated feedstock, heating the dewatered treated feedstock to form a vapor product, and condensing the vapor product to form a pyrolysis oil, wherein the pyrolysis oil contains less than 30% oxygen by weight.
    Type: Grant
    Filed: January 4, 2013
    Date of Patent: March 17, 2015
    Assignee: University of Maine System Board of Trustees
    Inventors: William Joseph DeSisto, Marshall Clayton Wheeler, Adriaan R. P. van Heiningen
  • Patent number: 8981640
    Abstract: A first device may be provided in some embodiments. The first device may comprise a substrate, a first emissive region, and a second emissive region, where the first emissive region and the second emissive region may comprise a contiguous area. The first device may further comprise a first electrode disposed over the substrate that extends across the first and the second emissive regions, and an organic layer disposed over the substrate that extends across the first and second emissive regions, where the organic layer comprises the same emissive material across the first and the second emissive regions. The first device may further include a second electrode disposed over the substrate that extends across the first and second emissive regions, where the second electrode includes a patterned layer of conductive material that is disposed in the first emissive region and that is not disposed in the second emissive region.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: March 17, 2015
    Assignee: Universal Display Corporation
    Inventors: Peter Levermore, Huiqing Pang, Prashant Mandlik
  • Patent number: 8980608
    Abstract: High molecular weight heparosan polymers are described, as are methods of producing and using the high molecular weight heparosan polymers.
    Type: Grant
    Filed: April 1, 2013
    Date of Patent: March 17, 2015
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Paul L. DeAngelis, Phillip Pummill, Regina C. Visser
  • Patent number: 8981752
    Abstract: An energy-based oriented switching mode power supply includes a bi-directional converter having an energy input and a load output, and an energy based pulsed generator connected between the energy input and the load output for outputting a gate voltage signal controlling how much energy is supplied from the energy input. The energy based pulsed generator receives a clock signal and outputs the gate voltage signal according to the load output of the bi-directional converter when the clock signal is at a high level. Accordingly, the switching mode power supply achieves a hybrid of PWM and PFM, depending on the energy demand of the load output, for a fast transient response and a small voltage ripple whilst improving power efficiency over a wide load range.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: March 17, 2015
    Assignee: National Chung Cheng University
    Inventors: Chung-Hsun Huang, Chao-Chun Chen
  • Patent number: 8980117
    Abstract: Provided is a piezoelectric material having a high Curie temperature and satisfactory piezoelectric characteristics, the piezoelectric material being represented by the following general formula (1): A(ZnxTi(1-x))yM(1-y)O3??(1) where A represents a Bi element, M represents at least one element selected from Fe, Al, Sc, Mn, Y, Ga, and Yb; x represents a numerical value of 0.4?x?0.6; and y represents a numerical value of 0.17?y?0.60.
    Type: Grant
    Filed: January 1, 2010
    Date of Patent: March 17, 2015
    Assignees: Canon Kabushiki Kaisha, Tokyo Institute of Technology, Sophia University, National Institute of Advanced Industrial Science and Technology
    Inventors: Makoto Kubota, Toshihiro Ifuku, Hiroshi Funakubo, Keisuke Yazawa, Hiroshi Uchida, Takashi Iijima, Bong-yeon Lee
  • Patent number: 8980455
    Abstract: The present disclose provides a lithium-ion battery with a gas-releasing and explosion-proof safety valve, which comprises a casing and a battery core. The casing includes an opening that is sealed by a thermal cover, on which a safety valve is disposed. The safety valve comprises a safety cover and a pressure filter. A middle portion of the safety cover includes a through hole. The pressure filter is affixed to the middle portion of the safety cover and has numerous pores. The safety cover and thermal cover are hooked together. The present invention offers multiple advantages. Firstly, simplified structure without aging issue enhances the safety and reliability of the battery. Secondly, during operation, gas is ventilated when an internal pressure of the battery reaches a certain threshold value to avoid rupture of the battery casing. Thirdly, with enhanced performance of the battery, the cycle life of the battery is greatly increased.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: March 17, 2015
    Assignee: Zhejiang University
    Inventor: Zhi Guo
  • Patent number: 8980549
    Abstract: The present invention relates to methods for diagnosing, staging, prognosticating and treating melanoma based on evaluating the expression of specific patterns of oncogenic or suppressive microRNA (miR) molecules in a patient in need thereof.
    Type: Grant
    Filed: August 1, 2011
    Date of Patent: March 17, 2015
    Assignees: Ramot at Tel Aviv University Ltd., Tel Hashomer Medical Research Infrastructure and Services Ltd.
    Inventors: Gal Markel, Eyal Greenberg, Noam Shomron, Liat Edry, Jacob Schachter
  • Patent number: 8980656
    Abstract: A new method for forming an array of high aspect ratio semiconductor nanostructures entails positioning a surface of a stamp comprising a solid electrolyte in opposition to a conductive film disposed on a semiconductor substrate. The surface of the stamp includes a pattern of relief features in contact with the conductive film so as to define a film-stamp interface. A flux of metal ions is generated across the film-stamp interface, and a pattern of recessed features complementary to the pattern of relief features is created in the conductive film. The recessed features extend through an entire thickness of the conductive film to expose the underlying semiconductor substrate and define a conductive pattern on the substrate. The stamp is removed, and material immediately below the conductive pattern is selectively removed from the substrate. Features are formed in the semiconductor substrate having a length-to-width aspect ratio of at least about 5:1.
    Type: Grant
    Filed: October 14, 2010
    Date of Patent: March 17, 2015
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Xiuling Li, Nicholas X. Fang, Placid M. Ferreira, Winston Chern, Ik Su Chun, Keng Hao Hsu
  • Patent number: 8979534
    Abstract: Provided is an acellular mammalian tooth-shaped scaffold including a compound that is chemotactic, osteogenic, dentinogenic, amelogenic, or cementogenic. Also provided is a method of replacing a tooth in the mouth of a mammal, where the tooth is absent and a tooth socket is present in the mouth at the position of the absent tooth. The method includes implanting an acellular scaffold having the shape of the missing tooth into the tooth socket. Additionally, a method of making a tooth scaffold is provided. The method includes synthesizing an acellular scaffold in the shape of a mammalian tooth and adding at least one compound that is chemotactic, osteogenic, dentinogenic, amelogenic, or cementogenic.
    Type: Grant
    Filed: June 17, 2010
    Date of Patent: March 17, 2015
    Assignee: The Trustees of Columbia University in the City of New York
    Inventor: Jeremy J. Mao
  • Patent number: 8980185
    Abstract: A microreactor for preparing a radiolabeled complex or a biomolecule conjugate comprises a microchannel for fluid flow, where the microchannel comprises a mixing portion comprising one or more passive mixing elements, and a reservoir for incubating a mixed fluid. The reservoir is in fluid communication with the microchannel and is disposed downstream of the mixing portion. A method of preparing a radiolabeled complex includes flowing a radiometal solution comprising a metallic radionuclide through a downstream mixing portion of a microchannel, where the downstream mixing portion includes one or more passive mixing elements, and flowing a ligand solution comprising a bifunctional chelator through the downstream mixing portion. The ligand solution and the radiometal solution are passively mixed while in the downstream mixing portion to initiate a chelation reaction between the metallic radionuclide and the bifunctional chelator. The chelation reaction is completed to form a radiolabeled complex.
    Type: Grant
    Filed: August 25, 2011
    Date of Patent: March 17, 2015
    Assignees: The Board of Trustees of the University of Illinois, Washington University
    Inventors: David E. Reichert, Paul J. A. Kenis, Tobias D. Wheeler, Amit V. Desai, Dexing Zeng, Birce C. Önal